A Study to Investigate the Possible Causes of Secondary Effects During Use of Peripheral Midline Type Catheter in Patients Hospitalized in Different Care Settings

Safety and Efficiency oh the Use of Midline Peripheral Venous Catheter (MIDES)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04391205

Acronym

MIDES

Enrollment

211

Registered

2020-05-18

Start date

2017-04-26

Completion date

2019-02-28

Last updated

2020-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Extremity Deep Vein Thrombosis, Secondary

Keywords

Midline, peripheral venous catheter, vascular access device, deep venous thrombosis

Brief summary

Although the use of peripheral venous catheters (CVP) with brachial insertion with echo-guide (Midline) has increased significantly over the last 5-10 years, there are no sensitive data concerning complications in the literature during their use, particularly as regards incidence of thrombotic complication.The prospective observational study will enroll all the patients admitted to Home Health Hospitalization service, Geriatric Department and Intermediate Care service, to whom a Midline-type CVP will be placed for infusional therapy and who will give their consent to participate.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

45 Years to No maximum

Healthy volunteers

Inclusion criteria

* Subjects admitted to wards adhering to the study (Home Health Hospitalization service, Geriatric Department and Intermediate Care service) * Subjects submitted to Midline type venous catheter insertion

Exclusion criteria

* History of deep venous thrombosis or pulmonary embolism * Be hospitalized for less than a week

Design outcomes

Primary

Measure	Time frame	Description
Number of participants with Peripheral deep venous thrombosis (DVP) suspected with Compression ultrasound (CUS) and confirmed by echodoppler	Once a week from the implant day until CVP removal or patient discharge, whichever came first, assessed up to 40 days	Deep vein thrombosis is investigated with Compression ultrasound (CUS) technique, scheduled once a week from the implant day or performed at the time of occurrence of device malfunctions or at the onset of symptoms resulting from thrombotic complications; echodoppler tecnique is used to confirm diagnosis of thrombosis.

Countries

Italy

Outcome results